Quality of life in family members of vitiligo patients: A questionnaire study in Saudi Arabia

American Journal of Clinical Dermatology

Volumn 14, Issue 6, 2013, Pages 489-495

  Bin Saif, Ghada A ^a   Al Balbeesi, Amal O ^a   Binshabaib, Rawan ^a   Alsaad, Deema ^a   Kwatra, Shawn G ^b   Alzolibani, Abdullateef A ^c   Yosipovitch, Gil ^d  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c QASSIM UNIVERSITY   (Saudi Arabia)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT TOOL; DERMATOLOGY LIFE QUALITY INDEX; DISEASE ASSOCIATION; FAMILY; FAMILY DERMATOLOGY LIFE QUALITY INDEX; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SAUDI ARABIA; SEX DIFFERENCE; SOCIAL ASPECT; VALIDATION PROCESS; VITILIGO; WELLBEING;

ADOLESCENT; ADULT; AGED; EDUCATIONAL STATUS; FAMILY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SAUDI ARABIA; SEX FACTORS; TIME FACTORS; VITILIGO; YOUNG ADULT;

EID: 84890447206     PISSN: 11750561     EISSN: 11791888     Source Type: Journal    
DOI: 10.1007/s40257-013-0037-5     Document Type: Article

References (28)

1. Parsad D, Dogra S, Kanwar AJ. Quality of life in patients with vitiligo. Health Qual Life Outcomes. 2003;1:58.
2. Al Robaee AA. Assessment of quality of life in Saudi patients with vitiligo in a medical school in Qassim province, Saudi Arabia. Saudi Med J. 2007;28:1414-7.
3. Karelson M, Silm H, Kingo K. Quality of life and emotional state in vitiligo in an Estonian sample: comparison with psoriasis and healthy controls. Acta Derm Venereol. 2012. doi: 10.2340/00015555-1520.
4. Papadopoulos L, Bor R, Legg C. Coping with the disfiguring effects of vitiligo: a preliminary investigation into the effects of cognitive-behavioural therapy. Br J Med Psychol. 1999;72:385-96.
5. Stangier U, Ehlers A, Gieler U. Measuring adjustment to chronic skin disorders: validation of a self-report measure. Psychol Assess. 2003;15:532-49.
6. Trask PC, Paterson AG, Hayasaka S, et al. Psychosocial characteristics of individuals with non-stage IV melanoma. J Clin Oncol. 2001;19:2844-50.
7. Koo JYM, Lee CS, editors. Psychocutaneous medicine. New York: Marcel Dekker; 2003.
8. Lu Y, Duller P, van der Valk PGM, Evers AWM. Helplessness as predictor of stigmatization in patients with psoriasis and atopic dermatitis. Dermatol Psychosom. 2003;4:146-50.
9. Evers AW, Kraaimaat FW, van Lankveld W, et al. Beyond unfavorable thinking: the Illness Cognition Questionnaire for chronic diseases. J Consult Clin Psychol. 2001;69:1026-36.
10. Lawson V, Lewis-Jones MS, Finlay AY, et al. The family impact of childhood atopic dermatitis: the Dermatitis Family Impact questionnaire. Br J Dermatol. 1998;138:107-13.
11. Titman PS, Barker C, Smith CH. The psychological impact of chronic eczema on children and their families. Br J Dermatol. 2001;145(Suppl.59): 128-9.
12. Ben-Gashir MA, Seed PT, Hay RJ. Are quality of family life and disease severity related in childhood atopic dermatitis? J Eur Acad Dermatol Venereol. 2002;16:455-62.
13. Richards HL, Chong SLP, Mason DL, Griffiths CEM. The impact of psoriasis on healthy partners of patients with psoriasis. Br J Dermatol. 2002;147(Suppl.62):40.
14. Eghlileb AM, Davies EE, Finlay AY. Psoriasis has a major secondary impact on the lives of family members and partners. Br J Dermatol. 2007;156:1245-50.
15. Finlay AY, Khan GK. Dermatology Life Quality Index, a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210-6.
16. Lewis VJ, Finlay AY. 10 years experience of the Dermatology Life Quality Index. J Invest Dermatol Symp Proc. 2004;9:169-80.
17. Basra MKA, Sue-Ho R, Finlay AY. The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease. Br J Dermatol. 2007;156:528-38.
18. Basra MK, Finlay AY. The family impact of skin diseases: the greater patient concept. Br J Dermatol. 2007;156:929-37.
19. Mielck A, Reitmeir P, Vogelmann M, Leidl R. Impact of educational level on health-related quality of life (HRQL): results from Germany based on the EuroQol 5D (EQ-5D). Eur J Public Health. 2013;23:45-9.
20. Porter J, Beuf AH, Nordlund JJ, Lerner AB. Psychological reaction to chronic skin disorders: a study of patients with vitiligo. Gen Hosp Psychiatry. 1979;1:73-7.
21. Porter JR, Beuf AH, Lerner A, Nordlund J. Psychosocial effect of vitiligo: a comparison of vitiligo patients with "normal" control subjects, with psoriasis patients, and with patients with other pigmentary disorders. J Am Acad Dermatol. 1986;15:220-4.
22. Borimenjad L, Yekta ZP, Nusrabadi AN, Firooz A. Quality of life with vitiligo: comparison of male and female Muslim patients in Iran. Gend Med. 2006;3:124-30.
23. Holm EA, Esmann S, Jemec GB. Does visible atopic dermatitis affect quality of life more in women than in men? Gend Med. 2005;1:125-230.
24. Zachariae R, Zachariae C, Ibsen HH, et al. Psychological symptoms and quality of life of dermatology outpatients and hospitalized dermatology patients. Acta Derm Venereol. 2004;84:205-12.
25. Gelford J, Feldman S, Stern R, et al. Determinants of quality of life in patients with psoriasis: a study from US population. J Am Acad Dermatol. 2004;51:704-8.
26. Sampogna F, Tabolli S, Di Pietro C, et al. The evaluation of family impact of recessive dystrophic epidermolysis bullosa using the Italian version of the Family Dermatology Life Quality Index. J Eur Acad Dermatol Venereol. 2012. doi: 10.1111/j.1468-3083.2012.04682.x.
27. Al-Mubarak L, Al-Mohanna H, Al-Issa A, et al. Quality of life in Saudi vitiligo patients. J Cutan Aesthet Surg. 2011;4:33-7.
28. Linthorst Homan MW, Spuls PI, de Korte J, et al. The burden of vitiligo: patient characteristics associated with quality of life. J Am Acad Dermatol. 2009;61:411-20.